Stock Market News3 months FDA Accepts Agios’ sNDA for Pyrukynd in Thalassemia Zacks
If approved, AGIO’s Pyrukynd will be the first oral therapy for all thalassemia subtypes. A final decision is expected by Sep. 7.
X11 hours LXRX Stock Moves Up 30% in a Week: What is Driving This Rally? Zacks
X12 hours Is Regeneron Pharmaceuticals, Inc. (REGN) The Most Profitable Biotech Stock To Buy Right Now? Yahoo Finance
X13 hours APLS’ Empaveli sNDA for 2 Rare Kidney Diseases Gets FDA Priority Tag Zacks
X13 hours Milestone Pharmaceuticals downgraded to Hold from Buy at TD Cowen Yahoo Finance
X13 hours What Makes Catalyst Pharmaceuticals (CPRX) an Investment Choice? Yahoo Finance
X1 day Will Pfizer (PFE) Beat Estimates Again in Its Next Earnings Report? Zacks
X1 day Can Johnson & Johnson (JNJ) Keep the Earnings Surprise Streak Alive? Zacks
X1 day Here’s Why Verrica Pharmaceuticals (VRCA) Is a Great ‘Buy the Bottom’ Stock Now Zacks
X1 day SNY Gets FDA Nod for First Ever Hemophilia Drug in the United States Zacks
X2 days Why Biotech Stocks Like Recursion Pharmaceuticals, CRISPR Therapeutics, and Summit Therapeutics Plunged Today Yahoo Finance
X2 days JAZZ or ARGX: Which Is the Better Value Stock Right Now? Zacks
X3 days Jim Cramer on Vertex Pharmaceuticals (VRTX): “Revolutionary Pain Drug on the Horizon!” Yahoo Finance
X4 days Regeneron Pharmaceuticals, Inc. (REGN): Among Blue Chip Stocks to Invest in at 52-Week Lows Yahoo Finance
X4 days Is Jazz Pharmaceuticals (JAZZ) the Best Mid Cap Biotech Stock to Buy? Yahoo Finance
X5 days Is Vertex Pharmaceuticals (VRTX) The Most Expensive Stock Insiders Are Dumping In March? Yahoo Finance
X5 days Is Madrigal Pharmaceuticals (MDGL) The Most Expensive Stock Insiders Are Dumping In March? Yahoo Finance
X5 days Vertex Pharmaceuticals (VRTX) Stock Moves -1.96%: What You Should Know Zacks
X5 days Mirum Pharmaceuticals (MIRM) Down 1.9% Since Last Earnings Report: Can It Rebound? Zacks
X5 days Why Is Acadia (ACAD) Down 11.1% Since Last Earnings Report? Zacks
X5 days Novo Nordisk Inks Its Second Big Obesity Deal In A Week — And It’s Not For A GLP-1 Investor's Business Daily
X6 days Corvus Pharmaceuticals’ Short Runway Overshadows Soquelitinib’s Promising Trials Seeking Alpha
X6 days Corvus Pharmaceuticals: Now At Cruising Altitude Seeking Alpha
X6 days Vertex Pharmaceuticals (VRTX) Advances While Market Declines: Some Information for Investors Zacks
X6 days Jazz (JAZZ) Down 9.2% Since Last Earnings Report: Can It Rebound? Zacks
X1 week All You Need to Know About Terns Pharmaceuticals (TERN) Rating Upgrade to Buy Zacks
XThe Stock Market News
The Stock Market News is a financial news aggregator for traders and investors that proposes to you the latest breaking news headlines on global financial markets, economy and business. Live trading analysis, opinions and forecasts on current stock market, currencies (Forex), cryptocurrency, commodities futures, ETFs, funds, bonds, rates and more. Disclaimer: by using any material of this website, you acknowledge and agree that TheStockMarketNews.com is not responsible for the content, actions or any legal issues arising from third-party websites; materials of this website are not financial advice or call to actions. Trading and investing in financial instruments involve high risks including the risk of investment loss.